News-Medical.Net on MSN

Rare immune events link Epstein Barr virus to early multiple sclerosis damage

The current study shows that the Epstein–Barr virus can interfere with the normal control of B cells. One viral protein ...
Acsh.org

Unmasking Multiple Sclerosis’s Autoimmune Warfare

Multiple sclerosis, or MS, casts a shadow over the lives of millions worldwide, its complexities challenging both patients and researchers. Stemming from autoimmune assaults on the nervous system, ...
Healio

VIDEO: JAK inhibitors may enable management of multiple autoimmune diseases with less medication

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.
Seeking Alpha

Kyverna Therapeutics Highlights Potential of KYV-101 in Multiple Sclerosis with Data from Phase 1 Investigator-Initiated Trials to be Presented at ECTRIMS

EMERYVILLE, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics (KYTX), Inc. , a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune ...
National Herald

Winter, pollution, changing lifestyle surging autoimmune diseases in women

The burden of autoimmune diseases is steadily rising, particularly among women, and the winter months — compounded by high ...
Healthline

What Is the Difference Between Guillain-Barré Syndrome and Multiple Sclerosis?

Both Guillain-Barré syndrome and multiple sclerosis involve an autoimmune attack on the nervous system. Guillain-Barré syndrome affects the peripheral nervous system, while multiple sclerosis impacts ...
PharmiWeb

Candid Therapeutics Plans to Initiate Multiple Phase 2 Studies Following Promising Clinical Data of T-cell Engagers in Autoimmune Diseases

T-cell engagers (TCEs) have the most promising product profile across all deep B-cell depleting modalitiesCizutamig (BCMA TCE) positioned as first and best-in-class for autoimmune diseasesOver 60 ...